Pendal Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$309K Buy
+25,322
New +$316K ﹤0.01% 436
2020
Q1
Sell
-9,241
Closed -$272K 446
2019
Q4
$272K Sell
9,241
-75
-0.8% -$2.04K ﹤0.01% 365
2019
Q3
$248K Sell
9,316
-6,025
-39% -$181K ﹤0.01% 405
2019
Q2
$519K Sell
15,341
-856
-5% -$27.8K 0.01% 347
2019
Q1
$519K Buy
16,197
+8,459
+109% +$260K 0.01% 361
2018
Q4
$244K Buy
7,738
+6,369
+465% +$209K ﹤0.01% 377
2018
Q3
$47.8K Buy
+1,369
New +$48.1K ﹤0.01% 440

Other funds holding ELAN

Pendal Group's ELAN Position: Q4 2022 in Review

Pendal Group opened a new position in Elanco Animal Health (ELAN) in Q4 2022: 25,322 shares worth $309K. The stake represents ﹤0.01% of the portfolio and ranks #436 among its holdings. This is a return to the name: Pendal Group previously reported a position in ELAN as recently as Q4 2019.

Pendal Group first reported a position in ELAN in Q3 2018 and has held it in 7 quarters since. The position peaked at $519K in Q1 2019. 403 funds tracked by Wall St. Rank hold ELAN as of Q4 2022.

  • Pendal Group held 25,322 shares of Elanco Animal Health worth $309K as of Q4 2022.
  • Elanco Animal Health was a new Pendal Group position in Q4 2022.
  • Elanco Animal Health made up ﹤0.01% of Pendal Group's portfolio in Q4 2022, its #436 holding.
  • Pendal Group first reported a position in Elanco Animal Health in Q3 2018 and has held it in 7 quarters since.
  • Pendal Group's Elanco Animal Health position peaked at $519K in Q1 2019.
  • 403 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2022.

Based on Pendal Group's 13F filing for Q4 2022, filed 19 Jan 2023.